Related Experiment Videos
Genetic testing for cystic fibrosis.
1Institute for Molecular Genetics, Baylor College of Medicine, Houston, Texas.
Pediatric Clinics of North America
|April 1, 1992
Summary
Cystic fibrosis (CF) affects 1 in 2000-4000 whites, with 1 in 25 being carriers. DNA testing for CF gene mutations is crucial for carrier screening and genetic counseling.
Area of Science:
- Medical Genetics
- Molecular Biology
- Genetic Epidemiology
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting 1 in 2000-4000 individuals of white descent.
- Approximately 1 in 25 individuals are heterozygous carriers of the CF gene.
- A single common mutation accounts for 70-75% of CF chromosomes, with other mutations present on the remainder.
Purpose of the Study:
- To discuss the implications of CF gene cloning and mutation identification for genetic testing.
- To evaluate the potential of population-based carrier screening for cystic fibrosis.
- To highlight CF as a model for understanding and managing genetic disorders.
Main Methods:
- Review of current understanding of CF genetics and mutation spectrum.
- Discussion of DNA analysis for carrier testing in relatives and partners.
- Assessment of population-based carrier screening feasibility and potential yield.
Main Results:
- DNA analysis is recommended for relatives of CF patients and partners of carriers.
- Population-based screening could identify approximately 72% of at-risk couples.
- Pilot studies are underway to evaluate screening feasibility.
Conclusions:
- Cystic fibrosis serves as a valuable model for genetic disorders, given its genetic basis and the advancements in testing.
- Gene therapy holds promise, and ongoing research addresses the complexities of CF genetics.
- Carrier testing and screening are essential components of reproductive planning for cystic fibrosis.